Key facts
- The EVERY Company’s last known valuation is $605.0M (Nov 2021).
- It has raised $309.8M across 1 recorded rounds; the latest was Later Stage VC (Series C) ($175.0M) in Nov 2021.
- Notable investors include SOSV, Temasek Holdings, IndieBio, OurCrowd, MicroVentures — 52 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 52 names
- ·Watchlist + deal alerts for The EVERY Company
Funding rounds
1 roundsAbout The EVERY Company
Producer of food items and probiotic beverages intended to offer animal-free proteins. The company's goods include nutritional supplements, as a nitrogenous matter boost for food and beverages, which contain necessary nutrients and have no added sugar, enabling customers to get healthy, sustainable, and affordable protein items.
- Industry
- Food Products
- Sector
- Consumer Products and Services (B2C)
- HQ
- Daly City, CA, United States
- Founded
- 2014
- Employees
- 127
- Website
- every.com/
- Ownership
- Privately Held (backing)
The EVERY Company doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in The EVERY Company shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on The EVERY Company in its N-PORT filings yet. We sweep new filings monthly.